|
Daily Medical Update
Obsessive-compulsive disorder
Friday, April 24, 2026
|
🔬 Practice-Changing Findings
Evidence from RCTs and meta-analyses published in the
last 12 months.
|
Journal of the American Academy of Child and Adolescent Psychiatry (2025) - Individual participant data meta-analysis
Key Findings
- SSRIs reduced CY-BOCS scores by 3.0 points versus placebo (95% CI 2.5-3.5), corresponding to a small effect size of 0.38.
- Response odds favored SSRIs over placebo (OR 1.89, 95% CI 1.45-2.45), while greater baseline severity predicted a lower chance of response.
📋 Practice Implication: For pediatric OCD, SSRIs remain evidence-based but should be framed as modestly effective monotherapy; children with more severe presentations may need earlier combination treatment and closer follow-up.
|
The British Journal of Psychiatry (2025) - Individual participant data meta-analysis
Key Findings
- Across 11 trials with 2372 adults, SSRIs improved YBOCS scores by 2.65 points more than placebo (95% CI 1.85-3.46; Hedges g 0.33).
- Response was more likely with SSRIs than placebo (OR 2.21, 95% CI 1.72-2.83; number needed to treat 7), and acceptability was similar between groups.
📋 Practice Implication: In adult OCD, SSRI efficacy is reliable but limited in magnitude, so clinicians should set realistic expectations and escalate to augmentation or psychotherapy rather than prolonging ineffective monotherapy.
|
The British Journal of Psychiatry (2026) - Network meta-analysis
Key Findings
- All CBT formats outperformed control conditions for OCD symptom reduction, with post-treatment effect sizes ranging from SMD -0.39 to -1.66.
- Individual, remote-delivery, and family-involved CBT were more effective versus group CBT by SMD -0.38 to -0.60, and most active formats were more acceptable than unguided self-help (relative risks 1.11-1.18).
📋 Practice Implication: When access to traditional in-person therapy is limited, remote and family-involved CBT appear clinically defensible substitutes, whereas unguided self-help should be reserved for lower-intensity situations.
|
Journal of Psychiatric Research (2026) - Systematic review and meta-analysis
Key Findings
- Across 9 randomized trials, ACT showed a moderate overall effect favoring symptom improvement over inactive controls and pharmacotherapy comparators.
- Sensitivity analyses showed no significant difference in symptom improvement versus psychological comparators between Eastern and Western study settings.
📋 Practice Implication: ACT looks most useful as an adaptable psychotherapy option when exposure-based CBT is unavailable, unacceptable, or needs augmentation, but the still-limited trial base argues against treating it as the default first-line therapy.
|
European Psychiatry (2025) - Systematic review and meta-analysis
Key Findings
- Compared with bipolar disorder alone, BD-OCD was associated with higher odds ratios for chronic mood episodes (9.42), rapid cycling (1.92), substance use disorders (1.39), and lifetime suicide attempts (1.85).
- BD-OCD was also associated with earlier bipolar onset, reduced functioning, and increased odds ratios for eating and panic disorders.
📋 Practice Implication: In patients with bipolar disorder, comorbid OCD should trigger a higher-acuity assessment because it marks a more complex and suicide-prone course that may need tighter care coordination across mood and anxiety treatment plans.
|
|
💡
Summary
Recent OCD evidence reinforces a stepped-care model: both adult and pediatric SSRI treatment outperform placebo, but effect sizes remain modest, while multiple CBT delivery formats retain meaningful efficacy beyond traditional in-person individual therapy. New synthesis also supports ACT as a plausible adjunct psychotherapy and identifies bipolar-OCD comorbidity as a higher-risk phenotype linked to suicidality, chronicity, and poorer functioning. Clinically, the strongest near-term signal is to match treatment intensity and monitoring to baseline severity, access constraints, and psychiatric comorbidity rather than assuming one standard pathway fits all patients.
|
|